En Es
Categories

Industry News

Philips Acquires Respiratory Technologies to Expand Product Portfolio

By HospiMedica International staff writers
29 May 2017

Image: Royal Philips has signed an agreement to acquire Respiratory Technologies, which will serve to expand the product portfolio of Philips (Photo courtesy of iStock).Royal Philips has signed an agreement to acquire Respiratory Technologies, Inc., which provides airway clearance solution for patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The addition of RespirTech’s vest therapy solution and capabilities to Philips’ respiratory care portfolio will further strengthen Philips’ solutions to manage care in the hospital and at home.

Philips’ solutions for managing COPD, asthma and other respiratory conditions at home or in the hospital range from air purification to therapies - including airway clearance devices, oxygen, ventilation and respiratory drug delivery systems - and monitoring. RespirTech’s offerings will allow Philips to accelerate its growth in respiratory care, especially for COPD patients with bronchiectasis, an often under-diagnosed and undertreated co-morbidity.

RespirTech’s inCourage System technology, a proprietary design that pulsates a vest worn by the patient at home, complements Philips’ solutions. Additionally, RespirTech has established a proprietary COPD/bronchiectasis registry involving more than 5,000 patients who are using its vest therapy. The collected data includes patient-reported changes in lung function, hospitalizations, antibiotic use and quality of life after initiating vest therapy. RespirTech’s clinical support program for managing respiratory patients in the home will support Philips’ aim to deliver cost-effective, clinically focused service programs, such as its sleep-focused Patient Adherence Management Service (PAMS).

“With this transaction, we will broaden our portfolio with a proven therapy to enable patients with chronic respiratory disorders manage their condition and receive the care they need in the home,” said John Frank, Philips’ Business Leader, Sleep & Respiratory Care. “RespirTech’s vest therapy can be applied to a range of respiratory conditions and various neuromuscular diseases, where patients’ compromised abilities to cough often leads to serious respiratory complications and associated higher care costs. By helping these patients help themselves, we aim to enhance the patient’s quality of life and reduce the overall cost of care.”



E-mail Print
FaceBook Twitter Google+ Linked in

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare with a strong presence in cardio-pulmonary, oncology and women’s health
More info

More articles about Philips Healthcare

09 Nov 2021
Philips Acquires Medical Technology Company Cardiologs to Expand Cardiac Diagnostics and Monitoring Portfolio
Royal Philips (Amsterdam, the Netherlands) has signed an agreement to acquire Cardiologs (Paris, France), a medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology.
Read More
13 Apr 2021
Philips Collaborates with AI Startup Ibex to Accelerate Adoption of AI-Powered Digital Pathology Solutions
Royal Philips (Amsterdam, The Netherlands) and Ibex Medical Analytics (Tel Aviv, Israel) have entered into a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
Read More
09 Mar 2021
Philips' Diagnostic X-ray Suite to Incorporate Lunit's AI Software
Philips Healthcare (Amsterdam?, the Netherlands) has entered into a collaboration with Lunit (Seoul, Korea) that will make Lunit's AI software accessible to users of Philips' diagnostic X-ray solutions.
Read More
20 Jan 2021
Philips Acquires Capsule Technologies to Expand Leadership in Patient Care Management Solutions for Hospitals
Royal Philips (Amsterdam, the Netherlands) has signed an agreement to acquire Capsule Technologies, Inc. (Andover, MA, USA), a provider of medical device integration and data technologies for hospitals and healthcare organizations.
Read More
10 Mar 2020
Philips Receives Global AI for Enhanced Radiology Interpretation Company of The Year Award from Frost & Sullivan
 Philips Healthcare (Amsterdam?, Noord-Holland) has been recognized with the 2019 Global Company of the Year Award by Frost & Sullivan, based on its recent analysis of the global market for Artificial Intelligence (AI) for enhanced radiology interpretation market. Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.
Read More
05 Apr 2019
Philips Acquires Direct Radiology Teleradiology Platform
Royal Philips is expanding its radiology solutions portfolio with innovative teleradiology services, aimed at addressing the increasing shortage of radiologists, as well as the pressing need to improve access to precision diagnoses.
Read More
30 Oct 2018
Philips Launches Start-Up AI Collaboration Program
Royal Philips has launched its first global start-up collaboration program involving the company’s innovation hubs in Cambridge, US, Eindhoven, the Netherlands, Bangalore, India and Shanghai, China focused on the application of artificial intelligence (AI) in healthcare. The program focuses on the application of AI-based clinical decision support tools, such as image interpretation, analysis and integration, and workflow tools, such as intelligent treatment plans for radiology, ultrasound and oncology.
Read More
22 Aug 2018
Intel and Philips Partner to Speed Up Imaging Analysis Using AI
Intel Corporation and Royal Philips have tested two healthcare use cases for deep learning inference models: one on X-rays of bones for bone-age-prediction modeling and the other on CT scans of lungs for lung segmentation. In these tests, which were conducted using Intel Xeon Scalable processors and the OpenVINO toolkit, the researchers achieved a speed improvement of 188 times for the bone-age-prediction model and 38 times for the lung-segmentation model over the baseline measurements. These tests show that healthcare organizations can implement artificial intelligence (AI) workloads without expensive hardware investments.
Read More

Additional news

28 Sep 2022
Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology
The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030, driven by the rising prevalence of infectious diseases, such as tuberculosis and COVID-19, and technological advancements.
Read More
27 Sep 2022
Mindray Showcases Hematology Innovations at ISLH 2022
Mindray (Shenzhen, China) showcased its hematology innovations and academic achievements to medical experts from Europe and around the world at the International Symposium on Technological Innovations in Laboratory Hematology (ISLH 2022) held between September 8-10 in Bologna, Italy.
Read More
23 Sep 2022
Parker Labs Partners with Tristel to Deliver Ultrasound Disinfectant for U.S. Market
Parker Laboratories Inc. (Fairfield, NJ, USA) has entered a commercial partnership with Tristel plc (Newmarket, UK) to manufacture and distribute the company's disinfectant foams for U.S. markets.
Read More
19 Sep 2022
Pluslife and FIND Set Collaborate to Empower LMICs with Next-Gen POC Molecular Testing in Women’s Healthcare
Guangzhou Pluslife Biotechnology (Pluslife, Guangzhou, China) and the Foundation for Innovative New Diagnostics (FIND, Geneva, Switzerland) have entered into a strategic collaboration to support low- and middle-income countries (LMICs) in the development of diagnostic tools for women’s healthcare by providing access to next generation point of care (POC) molecular testing technology.
Read More
19 Sep 2022
RSNA 2022 to Showcase Latest Technologies for Advancing Patient Care
The Radiological Society of North America’s (RSNA, Oak Brook, IL, USA) has announced Technical Exhibits highlights for their 108th Scientific Assembly and Annual Meeting (RSNA 2022) held in Chicago at McCormick Place, Nov. 27 – Dec. 1.
Read More
16 Sep 2022
International Hospital Federation Awards 2022 Finalists Announced
The International Hospital Federation (IHF; Geneva, Switzerland) has announced the finalists of the IHF Awards 2022 after scoring entries in seven categories.
Read More
16 Sep 2022
Intelerad Acquires Life Image to Create World’s Largest Medical Image Exchange Network
Intelerad Medical Systems (Raleigh, NC, USA), a leading global provider of enterprise imaging solutions, has acquired Life Image (Newton, MA, USA), one of the largest image exchange networks of curated clinical and imaging data, creating the largest medical image exchange network in the world and laying the groundwork for the elimination of costly CDs as the primary means of image transfer.
Read More
13 Sep 2022
Global Diagnostic Labs Market Driven by Increased POCT Testing and Smart Portable Devices
The global diagnostic labs market is projected grow at a CAGR of 8.3% from over USD 297 billion in 2021 to more than USD 514 billion by 2028, driven by the increasing prevalence of chronic diseases, growing use of POC diagnostics, and rising healthcare expenditures.
Read More
12 Sep 2022
ECR 2023 Now Set to Take Place from 1-5 March in Vienna
The European Society of Radiology (ESR, Vienna, Austria) has announced that the European Congress of Radiology (ECR) 2023 will now take place on March 1-5, 2023 in Vienna.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions